Literature DB >> 17029340

Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms.

Ayman A Elsayed1, Christopher J Moran, DeWitte T Cross, Colin P Derdeyn, Thomas K Pilgram, James M Milburn, Ralph G Dacey, Michael N Diringer.   

Abstract

OBJECT: The goal in this study was to determine if there was a change in intracranial venous diameters after endovascular treatment of carotid distribution vasospasm caused by subarachnoid hemorrhage.
METHODS: The venous diameters were measured in all patients who received intraarterial papaverine and/or balloon angioplasty for treatment of vasospasm during the study period of 3 years. To evaluate the veins of Labbe and Trolard, the straight sinus, and the superior sagittal sinus (SSS), measurements were performed in a blinded manner with the aid of a magnification loupe. Predetermined sites were evaluated on angiograms obtained before and after endovascular treatment. Forty-three treatments in 26 patients were included: 18 patients (33 territories) were treated with intraarterial papaverine alone, four (four territories) were treated with balloon angioplasty alone, and four (six territories) were treated with both papaverine infusion and angioplasty. The mean measured venous diameters increased significantly after addition of papaverine (10.9%), and also after combined papaverine and angioplasty (4.2%). There was no statistically significant increase in the mean venous diameters after angioplasty alone. If the initial intracranial pressure (ICP) was less than 15 mm Hg before treatment, the veins showed a greater tendency to dilate than if the initial ICP measurements were greater than 15 mm Hg. The straight sinus and the SSS increased more in diameter than the veins of Labbe and Trolard. There was no statistically significant correlation between the change in venous diameters with treatment and ICP.
CONCLUSIONS: Endovascular treatment produces measurable increases in intracranial venous diameters. However, these changes do not correlate with changes in ICP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17029340     DOI: 10.3171/foc.2006.21.3.16

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  4 in total

1.  Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage.

Authors:  Jai Jai Shiva Shankar; Marlise P dos Santos; Leonardo Deus-Silva; Cheemun Lum
Journal:  Neuroradiology       Date:  2010-06-05       Impact factor: 2.804

Review 2.  Current options for the management of aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm: a comprehensive review of the literature.

Authors:  Guilherme Dabus; Raul G Nogueira
Journal:  Interv Neurol       Date:  2013-10

3.  Disruption of the blood-brain barrier by intra-arterial administration of papaverine: a technical note.

Authors:  Johannes Platz; Krisztina Baráth; Emanuela Keller; Anton Valavanis
Journal:  Neuroradiology       Date:  2008-09-13       Impact factor: 2.804

4.  Utility of Screening for Cerebral Vasospasm Using Digital Subtraction Angiography.

Authors:  Eric J Arias; Sravya Vajapey; Matthew R Reynolds; Michael R Chicoine; Keith M Rich; Ralph G Dacey; Ian G Dorward; Colin P Derdeyn; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Rajat Dhar
Journal:  Stroke       Date:  2015-09-24       Impact factor: 7.914

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.